TrialEBioMedicine2025

Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL.

Berta González-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.